Ampliphi Biosciences (APHB) Sees Strong Trading Volume

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) saw unusually-high trading volume on Tuesday . Approximately 4,942,300 shares were traded during trading, an increase of 116% from the previous session’s volume of 2,287,360 shares.The stock last traded at $1.87 and had previously closed at $1.37.

Separately, HC Wainwright set a $5.00 target price on shares of Ampliphi Biosciences and gave the company a “buy” rating in a report on Wednesday, November 15th.

The company has a market capitalization of $13.01, a price-to-earnings ratio of -0.15 and a beta of 2.93.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2018/01/09/ampliphi-biosciences-aphb-sees-strong-trading-volume.html.

About Ampliphi Biosciences

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit